平成15年
Kawakami Y. Human melanoma antigens recognized by CD8+ T cells, in “Tumor Antigens Recognized by T cells and Antibodies” eds, Stauss H, Kawakami Y, and Parmiani G, Tumor Immunology Series, Taylor & Francis, NewYork , 2003..3:47-74.2003
Matsushita M, Yamazaki R, Ikeda H, and Kawakami Y. Preferentially Expressed Antigen of Melanoma (PRAME) in the Development of Diagnostic and Therapeutic Methods for Hematological Malignancies, Leukemia and lymphoma.44(3):439-444.2003 Mar
Kuwana M, Kawakami Y, and Ikeda Y. Suppression of autoreactive T-cell response to glycoprotein IIb-IIIa by blockade of CD40/CD154 interaction: implications for treatment of immune thrombocytopenic purpura. Blood.101(2):621-623.2003 Jan
Ogawa Y, Kuwana M, Yamazaki K, Mashima Y, Yamada M, Mori T, Okamoto S,Oguchi Y and Kawakami Y. Periductal Area as the Primary Site for T-Cell Activationin Lacrimal Gland Chronic Graft-Versus-Host Disease. Invest Ophthalmol Vis Sci.44(5):1888-1896.2003 May
Suzuki S, Tanaka K, Yasuoka H, Fukuuchi Y, Kawakami Y and Kuwana M. Autoreactive T cells to the P3A+ isoform of AChR subunit in myasthenia gravis,J Neuroimmunology .137(1-2):177-186.2003 Apr
Kawakami Y. Identification of Human Tumor Antigens Recognized by T-cells and Their Use for Immunotherapy. Int J Hematol.77(5):427-434.2003 Jun
Ishikawa T, Fujita T, Suzuki Y, Okabe S, Yuasa Y, Iwai T and Kawakami Y. Tumor-specific Immunological Recognition of Frameshift-mutated Peptides in Colon Cancer with Microsatellite Instability. Cancer Res.63(17):5564-5572.2003 Sep
Ikeda H, Matsushita M, Waisfisz Q, Kinoshita A, Oostra AB, Nieuwint AWM, De Winter JP, Hoatlin ME, Kawai Y, Sasaki MS, D’Andrea AD, Kawakami Y, Joenje H. Genetic Reversion in an AML Cell Line from a Fanconi Anemia Patient withBiallelic Mutations in BRCA2.Cancer Res.63(10):2688-2694.2003 May
Nagayama H, Sato K, Morishita M, Uchiyama K, Inazawa T, Yamazaki T, Enomoto M, Nakaoka T, Nakamura T, Maekawa T, Yamamoto A, Shimada S, Saida T, Kawakami Y, Tani K, Asano S, Takahashi TA, and Yamashita N. Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2. Melanoma Res.13(5):521-530.2003 Oct
Kuwana M, Okazaki Y, Kodama H, Izumi K, Yasuoka H, Ogawa Y, Kawakami Y, and Ikeda Y. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol.74(5):833-845.2003 Nov
Kajihara M, Kato S, Okazaki Y, Kawakami Y, Ishii M, Ikeda Y, Kuwana M. A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis. Hepatol.37(6):1267-1276.2003 Jun
Kuwana M, Pandey JP, Silver RM, Kawakami Y, and Kaburaki J. HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities. J Rheumatol.30(11):2392-2397.2003 Nov
Yasuoka H, Ihn H, Thomas AM, Hirakata M, Kawakami Y, Ikeda Y, Kuwana M. A novel protein highly expressed in testis is overexpressed in systemic sclerosis fibroblasts and targeted by autoantibodies.Immunol.171(12):6883-6890.2003 Dec